Neox
Early Detection of Deterioration in Preterm Neonates
Health Tech & Life Sciences
Non Active, Aug 2024 ceased to operate
Company Overview
Snapshot
Founded in January 2021, Neox operates with 1–10 employees. The company has raised $200,000 across one funding round from one investor. Neox ceased to operate in August 2024.
Business overview
Neox develops an advanced AI system designed for the early detection and prediction of deterioration in preterm neonates within neonatal intensive care units. Its core technology leverages AI algorithms to provide warnings 6 to 24 hours in advance, aiming to improve patient outcomes by enabling timely interventions. The company operates in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Digital Medical Diagnostics, serving healthcare providers globally.
Log in to access full profile ›Company Intelligence Q&A
- What is Neox's primary focus?
- Neox focuses on developing an advanced AI system for the early detection and prediction of deterioration in preterm neonates within neonatal intensive care units.
- When was Neox founded?
- Neox was founded in January 2021.
- What is the status of Neox?
- Neox ceased to operate in August 2024.
- What technology does Neox utilize?
- Neox utilizes an AI algorithm, incorporating deep learning, to predict deteriorations in neonates.
- What markets does Neox target?
- Neox targets the global market, specifically serving healthcare providers in the Digital Healthcare and Digital Medical Diagnostics sectors.